analyst
NG
NASDAQ · NGNE
Neurogene Inc.
Healthcare · Biotechnology
$32.09
Down-$0.32 (-0.99%)
Updated Sep 19, 2026, 5:52 AM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 329.3M
- P/E ratio
- -5.29
- Dividend yield
- 0.00%
- 52-week range
- $18.23 – $43.66
- Volume
- 1.39M
- Avg. volume
- 231.35K
Price performance
NGNE price history
1M range · 20 trading sessions · Daily adjusted prices
NGNE closed at $32.09 after 20 trading sessions, down 16.93% for the selected period.
- Last close
- $32.09
- Period change
- -16.93%
- Period low
- $32.09
- Period high
- $40.84
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $32.49 | $33.15 | $31.86 | $32.09 | 1.39M |
| Sep 17, 2026 | $35.36 | $35.635 | $32.04 | $32.41 | 171.61K |
| Sep 16, 2026 | $34.04 | $34.86 | $33.525 | $34.67 | 232.13K |
| Sep 15, 2026 | $35.04 | $35.04 | $33.46 | $33.69 | 147.61K |
| Sep 14, 2026 | $35.92 | $36.28 | $34.70 | $35.21 | 194.67K |
| Sep 11, 2026 | $36.50 | $37.64 | $35.38 | $35.48 | 181.39K |
| Sep 10, 2026 | $37.51 | $38.25 | $36.07 | $36.12 | 177.11K |
| Sep 9, 2026 | $38.04 | $40.42 | $37.86 | $37.88 | 193.18K |
| Sep 8, 2026 | $37.79 | $38.75 | $36.68 | $38.13 | 228.47K |
| Sep 4, 2026 | $37.25 | $39.38 | $36.5573 | $38.60 | 205.63K |
| Sep 3, 2026 | $38.74 | $39.19 | $36.65 | $37.61 | 255.22K |
| Sep 2, 2026 | $37.97 | $39.78 | $36.8618 | $38.36 | 252.96K |
| Sep 1, 2026 | $35.80 | $38.21 | $35.31 | $37.87 | 134.48K |
| Aug 31, 2026 | $36.13 | $36.64 | $35.26 | $36.24 | 120.39K |
| Aug 28, 2026 | $37.68 | $38.56 | $36.315 | $36.58 | 132.8K |
| Aug 27, 2026 | $38.50 | $39.81 | $37.39 | $37.86 | 149.92K |
| Aug 26, 2026 | $40.74 | $41.77 | $38.27 | $38.41 | 180.17K |
| Aug 25, 2026 | $40.09 | $42.01 | $39.125 | $40.84 | 504.34K |
| Aug 24, 2026 | $38.64 | $40.82 | $37.50 | $39.64 | 439.1K |
| Aug 21, 2026 | $38.41 | $39.44 | $37.535 | $38.63 | 346.58K |
Latest NGNE news
The latest Smart Investors Daily articles mentioning NGNE.
Stock researchCompany · Financials
Loading stock research…